HTTP/1.0 200 OK Content-Type: text/html
Pubdate: Thu, 18 Sep 2003 Source: Business Standard (India) Copyright: 2003, Business Standard Ltd. Contact: http://www.business-standard.com/ Details: http://www.mapinc.org/media/3082 Author: Devangshu Datta RX - A SMALL DOSE OF CANNABIS First-time visitors to The Netherlands are surprised to note sharply-pointed cannabis-leaf symbols at coffee-houses and pubs; places often frequented by people lighting up or eating hash omelettes and drinking hash tea. The Dutch have a laissez-faire attitude to cannabis. Holland ignores personal possession of up to 30 grams of such substances as marijuana (the dried flower, or "ganja"), hashish (the dried resin, or "charas") and bhang (the dried leaf). When the EU opened internal borders, Holland started receiving weekend "potfans" from France, Belgium and Germany. In effect, Dutch liberality led to the Eurozone easing its stance vis-a-vis soft drugs, though users from other nations risk punishment. Holland is now offering over-the-counter prescription sales of cannabis -- useful for victims of cancer, HIV, multiple sclerosis and amputees. It controls pain and nervous spasms with fewer side-effects and less addiction-related problems than the alternatives. Two Dutch companies have been issued licences to grow cannabis to sell to the health ministry, which in turn packages the drug in small tubs for supply to pharmacies. The drug is packaged as dried marijuana flowers (grass). As well as pharmacies, 80 hospitals and 400 doctors will be allowed to dispense five-gram doses of SIMM18 medical marijuana for 44 euros ($ 48) a tub and more potent Bedrocan at 50 euros. The health ministry recommends patients dilute the cannabis into tea or adapt asthma inhalers. Some doctors say cannabis increases risks of depression or schizophrenia; other studies suggest it has few side effects. If it is smoked, you're inhaling carcinogens including nicotine and tar. The cannabis plant contains over 60 cannabinoids, alkaloids that affect physical functions. The cannabinoids bind to two cannabinoid receptors in the body: CB1 and CB2. CB1 enhances appetite, reduces pain and eases muscle spasms -- and also produces psychotropic effects. CB2 is expressed by immune and inflammatory cells, acts as an anti-inflammatory and reduces irritable bowel syndrome. This combination of CB1 and CB2 alleviates the nausea associated with chemotherapy, reverses appetite loss in AIDS patients, and controls CNS motor diseases and certain types of pain. There are researchers, notably Jerusalem's Hebrew University professor Raphael Mechoulam, in university and pharmaceutical labs elsewhere who are trying to isolate specific effects. Mechoulam was the first to isolate tetra-hydra-cannabinol (THC), which causes the "high". He is now working on "THC-less" cannabis, though he believes that such drugs will be less effective at treating CNS problems. Cannabis is also offered in countries such as the UK, Canada and Australia as well as in a few US states. However, cannabis is available from a few sources and distribution is more controlled. Canadian cannabis-users have complained that the official "baggies" that are offered to members of a subscription programme, are of terrible quality. The UK is moving towards decriminalisation. A recent commission, the Advisory Council on Misuse of Drugs, sent a recommendation to the Home Secretary that cannabis should be treated as a "Schedule C" drug. Schedule C is of the same risk/criminal status as growth hormones or steroids. Possession is non-criminal. Class A drugs including ecstasy, cocaine, crack cocaine and heroin accounted for 99 percent of "the cost to society of drug use", according to the UK release. Analysts estimate that relaxing British cannabis laws could save about $ 71 million per annum and free up 500 police officers for other duties. Decriminalisation could be similarly beneficial to India, where scarce policing resources could be concentrated on chasing more dangerous substances such as heroin or RDX. In fact, cannabis was sold at state government shops until the Narcotics Drugs and Psychotropic Substances Act, 1985. This treats all drugs as equally dangerous. Decriminalisation would enable research into the medical properties of cannabis and help India cope with the flood of HIV cases that will emerge over the next few years. Since it is possible to make a strong scriptural case for religious use by practising Hindus, is it too much to hope that the relegalisation of cannabis will feature on Hindutva-vadis' future agenda? - --- MAP posted-by: Larry Stevens